Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CILASTATIN\IMIPENEM for Endocarditis: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 13 adverse event reports in the FDA FAERS database where CILASTATIN\IMIPENEM was used for Endocarditis.

Most Reported Side Effects for CILASTATIN\IMIPENEM

Side Effect Reports % Deaths Hosp.
Epilepsy 615 12.6% 3 128
Product use in unapproved indication 385 7.9% 25 53
Drug ineffective 321 6.6% 133 122
Delirium 309 6.3% 1 53
Off label use 248 5.1% 58 81
Pyrexia 168 3.5% 47 104
Seizure 155 3.2% 15 59
Nausea 145 3.0% 12 52
Vomiting 133 2.7% 16 48
Diarrhoea 122 2.5% 27 64
Drug reaction with eosinophilia and systemic symptoms 122 2.5% 12 90
Pathogen resistance 122 2.5% 39 54
Dyspnoea 115 2.4% 32 60
Condition aggravated 103 2.1% 31 62
Pneumonia 98 2.0% 37 59

Other Indications for CILASTATIN\IMIPENEM

Pneumonia (587) Anti-infective therapy (556) Infection (537) Product used for unknown indication (277) Mycobacterium abscessus infection (197) Sepsis (185) Tuberculosis (177) Antibiotic therapy (170) Nocardiosis (116) Lung infection (104)

Other Drugs Used for Endocarditis

VANCOMYCIN (733) DAPTOMYCIN (506) GENTAMICIN (425) RIFAMPIN (296) AMOXICILLIN (279) CEFTRIAXONE (254) LINEZOLID (186) LEVOFLOXACIN (86) CEFAZOLIN (77) MEROPENEM (75)

Related Pages

CILASTATIN\IMIPENEM Full Profile All Endocarditis Drugs CILASTATIN\IMIPENEM Demographics CILASTATIN\IMIPENEM Timeline